Acclaro Medical

Acclaro Medical

Private
Smithfield, Rhode IslandHealthcare & Life Scienceshttps://ultraclearlaser.com/

Last Round

Series B

May 29, 2025

Total Funding Raised

$23M

Momentum Score

25 /100

Company Overview

Acclaro Medical is a medical technology company that develops and markets energy-based medical solutions, including the UltraClear and AuraLux fiber laser systems for aesthetic and surgical applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

cold ablative laserUltraClear laserskin resurfacingfiber laserskin rejuvenationaesthetic laserenergy-based devicesCO2 laser alternativemedical aestheticsall skin typescosmetic laserlunchtime laser treatmentlaser facialdermatology devicesmedtechFDA cleared devicebeauty techlaser coring2910nm laser

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acclaro Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Acclaro Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMay 29, 2025

Key People

Founding team and executive leadership

Helen F.

Chief Executive Officer

Executive Team

Ally Jin

Chief Financial Officer

Executive Team

Acclaro Medical Investors

Notable investors and investment history

InvestorRounds
Bencao CapitalSeries B
AccelmedSeries B

Acclaro Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Acclaro Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Acclaro Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSmithfield, Rhode Island
Employee Range93
Year Founded2018
Last FundingMay 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.